Odilson M Silvestre1, Wilson Nadruz2, Gabriela Querejeta Roca3, Brian Claggett3, Scott D Solomon3, Maria C Mirabelli4, Stephanie J London5, Laura R Loehr6, Amil M Shah7. 1. Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts; Department of Internal Medicine, Federal University of Acre, Rio Branco, Acre, Brazil. 2. Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts; Department of Internal Medicine, University of Campinas, Campinas, Brazil. 3. Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts. 4. Rollins School of Public Health, Emory University, Atlanta, Georgia. 5. National Institute of Environmental Health Sciences, National Institutes of Health, Department of Health and Human Services, Research Triangle Park, North Carolina. 6. Gillings School of Public Health, University of North Carolina, Chapel Hill, North Carolina. 7. Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts. Electronic address: ashah11@partners.org.
Abstract
BACKGROUND: Pulmonary dysfunction predicts incident cardiovascular disease (CVD). OBJECTIVES: The purpose of this study was to evaluate whether longitudinal decline in lung function is associated with incident heart failure (HF), coronary heart disease (CHD), and stroke. METHODS: Among 10,351 participants in the ARIC (Atherosclerosis Risk In Communities) study free of CVD, rapid lung function decline was defined as the greatest quartile (n = 2,585) of decline in either forced expiratory volume in 1 s (FEV1) (>1.9% decline/year) or forced vital capacity (FVC) (>2.1% decline/year) over 2.9 ± 0.2 years. The relationship between rapid decline in FEV1 or FVC and subsequent incident HF, CHD, stroke, or a composite of these was assessed using multivariable Cox regression adjusting for the baseline spirometry value, demographics, height, body mass index, heart rate, diabetes, hypertension, low-density lipoprotein, use of lipid-lowering medication, N-terminal fragment of prohormone for B-type natriuretic peptide, and smoking. RESULTS: The mean age was 54 ± 6 years, 56% were women, and 81% were white. At 17 ± 6 years of follow-up, HF occurred in 14%, CHD 11%, stroke 6%, and the composite in 24%. Rapid decline in FEV1 and in FVC were both associated with a heightened risk of incident HF (hazard ratio [HR]: 1.17; 95% confidence interval [CI]: 1.04 to 1.33; p = 0.010; and HR: 1.27; 95% CI: 1.12 to 1.44; p < 0.001; respectively), with rapid decline in FEV1 most prognostic in the first year of follow-up (HR: 4.22; 95% CI: 1.34 to 13.26; p = 0.01). Rapid decline in FEV1 was also associated with incident stroke (HR: 1.25; 95% CI: 1.04 to 1.50; p = 0.015). CONCLUSIONS: A rapid decline in lung function, assessed by serial spirometry, is associated with a higher incidence of subsequent CVD, particularly incident HF.
BACKGROUND:Pulmonary dysfunction predicts incident cardiovascular disease (CVD). OBJECTIVES: The purpose of this study was to evaluate whether longitudinal decline in lung function is associated with incident heart failure (HF), coronary heart disease (CHD), and stroke. METHODS: Among 10,351 participants in the ARIC (Atherosclerosis Risk In Communities) study free of CVD, rapid lung function decline was defined as the greatest quartile (n = 2,585) of decline in either forced expiratory volume in 1 s (FEV1) (>1.9% decline/year) or forced vital capacity (FVC) (>2.1% decline/year) over 2.9 ± 0.2 years. The relationship between rapid decline in FEV1 or FVC and subsequent incident HF, CHD, stroke, or a composite of these was assessed using multivariable Cox regression adjusting for the baseline spirometry value, demographics, height, body mass index, heart rate, diabetes, hypertension, low-density lipoprotein, use of lipid-lowering medication, N-terminal fragment of prohormone for B-type natriuretic peptide, and smoking. RESULTS: The mean age was 54 ± 6 years, 56% were women, and 81% were white. At 17 ± 6 years of follow-up, HF occurred in 14%, CHD 11%, stroke 6%, and the composite in 24%. Rapid decline in FEV1 and in FVC were both associated with a heightened risk of incident HF (hazard ratio [HR]: 1.17; 95% confidence interval [CI]: 1.04 to 1.33; p = 0.010; and HR: 1.27; 95% CI: 1.12 to 1.44; p < 0.001; respectively), with rapid decline in FEV1 most prognostic in the first year of follow-up (HR: 4.22; 95% CI: 1.34 to 13.26; p = 0.01). Rapid decline in FEV1 was also associated with incident stroke (HR: 1.25; 95% CI: 1.04 to 1.50; p = 0.015). CONCLUSIONS: A rapid decline in lung function, assessed by serial spirometry, is associated with a higher incidence of subsequent CVD, particularly incident HF.
Authors: Sunil K Agarwal; Gerardo Heiss; R Graham Barr; Patricia P Chang; Laura R Loehr; Lloyd E Chambless; Eyal Shahar; Dalane W Kitzman; Wayne D Rosamond Journal: Eur J Heart Fail Date: 2012-02-25 Impact factor: 15.534
Authors: Sara Roversi; Leonardo M Fabbri; Don D Sin; Nathaniel M Hawkins; Alvar Agustí Journal: Am J Respir Crit Care Med Date: 2016-12-01 Impact factor: 21.405
Authors: Raphael Carandang; Sudha Seshadri; Alexa Beiser; Margaret Kelly-Hayes; Carlos S Kase; William B Kannel; Philip A Wolf Journal: JAMA Date: 2006-12-27 Impact factor: 56.272
Authors: Hans Petersen; Akshay Sood; Paula M Meek; Xian Shen; Yan Cheng; Steven A Belinsky; Caroline A Owen; George Washko; Victor Pinto-Plata; Emer Kelly; Bartolome Celli; Yohannes Tesfaigzi Journal: Chest Date: 2014-04 Impact factor: 9.410
Authors: Vasiliki V Georgiopoulou; Andreas P Kalogeropoulos; Bruce M Psaty; Nicolas Rodondi; Douglas C Bauer; Abida B Butler; Annemarie Koster; Andrew L Smith; Tamara B Harris; Anne B Newman; Stephen B Kritchevsky; Javed Butler Journal: Am J Med Date: 2011-04 Impact factor: 4.965
Authors: Hossein Bahrami; Richard Kronmal; David A Bluemke; Jean Olson; Steven Shea; Kiang Liu; Gregory L Burke; João A C Lima Journal: Arch Intern Med Date: 2008-10-27
Authors: Philipp Eickhoff; Arschang Valipour; Dora Kiss; Martin Schreder; Leyla Cekici; Kora Geyer; Robab Kohansal; Otto C Burghuber Journal: Am J Respir Crit Care Med Date: 2008-10-03 Impact factor: 21.405
Authors: Ramachandran S Vasan; Lisa M Sullivan; Ronenn Roubenoff; Charles A Dinarello; Tamara Harris; Emelia J Benjamin; Douglas B Sawyer; Daniel Levy; Peter W F Wilson; Ralph B D'Agostino Journal: Circulation Date: 2003-03-25 Impact factor: 29.690
Authors: Charles Antwi-Boasiako; Michael M Asare; Ibrahim Baba; Alfred Doku; Kevin Adutwum-Ofosu; Charles Hayfron-Benjamin; Chamila P Asare; Robert Aryee; Gifty Boatemaah Dankwah; John Ahenkorah Journal: Am J Blood Res Date: 2021-04-15
Authors: Jenna McNeill; Ariel Chernofsky; Matthew Nayor; Farbod N Rahaghi; Raul San Jose Estepar; George Washko; Andrew Synn; Ramachandran S Vasan; George O'Connor; Martin G Larson; Jennifer E Ho; Gregory D Lewis Journal: Eur Respir J Date: 2022-08-04 Impact factor: 33.795
Authors: Hannah R Whittaker; Jeanne M Pimenta; Deborah Jarvis; Steven J Kiddle; Jennifer K Quint Journal: Int J Chron Obstruct Pulmon Dis Date: 2020-11-25